ArrowMark Colorado Holdings’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59M | Hold |
314,762
| – | – | 0.06% | 206 |
|
|
2025
Q1 | $3.74M | Hold |
314,762
| – | – | 0.06% | 196 |
|
|
2024
Q4 | $5.93M | Hold |
314,762
| – | – | 0.08% | 181 |
|
|
2024
Q3 | $7.07M | Hold |
314,762
| – | – | 0.09% | 162 |
|
|
2024
Q2 | $6.57M | Hold |
314,762
| – | – | 0.08% | 179 |
|
|
2024
Q1 | $4.63M | Hold |
314,762
| – | – | 0.05% | 217 |
|
|
2023
Q4 | $3.25M | Hold |
314,762
| – | – | 0.04% | 218 |
|
|
2023
Q3 | $2.47M | Buy |
+314,762
| New | +$2.47M | 0.03% | 225 |
|